FractureDetect (FX)

K193417

Imagen Technologies, Inc. · cleared 2020-07-30 · product code QBS · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.3)
FractureDetect (FX) is a computer-assisted detection and diagnosis (CAD) software device to assist clinicians in detecting fractures during the review of radiographs of the musculoskeletal system.
Algorithmdeep learning algorithms for computer vision
source quote (p.5)
FX was developed using robust scientific principles and industry-standard deep learning algorithms for computer vision.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.7)
HIPAA Compliant

Validation studies (2)

Standalone

n=11,970 images

endpoints: detects fractures of the musculoskeletal system in radiographs with high sensitivity; high specificity; high Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC)

standards: FDA's Guidance for Industry and FDA Staff, “Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices."

Reader study (MRMC)

n=175 cases

endpoints: determine whether the diagnostic accuracy of readers aided by FX (“FX-Aided”) is superior to the diagnostic accuracy of readers unaided by FX (“FX-Unaided”) as determined by the Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) curve

Reported performance (6 observations)

sensitivity0.951CI 95% Wilson's Confidence Interval (CI): 0.940, 0.960
source quote (p.8)
The results of standalone testing demonstrated that FX detects fractures of the musculoskeletal system in radiographs with high sensitivity (0.951; 95% Wilson's Confidence Interval (CI): 0.940, 0.960)
specificity0.893CI 95% Wilson's CI: 0.886, 0.898
source quote (p.8)
high specificity (0.893; 95% Wilson's CI: 0.886, 0.898)
aurocas written: “auc0.982CI 95% Bootstrap CI: 0.9790, 0.9850
source quote (p.8)
and high Area Under the Curve (AUC) of the Receiver Operating Characteristic (ROC) (0.982; 95% Bootstrap CI: 0.9790, 0.9850).
aurocas written: “Reader AUC0.952CI 95% CI: 0.0127, 0.0685
source quote (p.11)
Reader AUC was significantly improved from 0.912 to 0.952, a difference of 0.0406 (95% CI: 0.0127, 0.0685), across the 175 cases within FX's Indications for Use, spanning 12 study types (anatomic areas of interest) (p=.0043).
sensitivityas written: “Reader sensitivity0.9CI 95% Wilson's CI: 0.880, 0.917
source quote (p.11)
Reader sensitivity improved from 0.819 (95% Wilson's CI: 0.794, 0.842) to 0.900 (95% Wilson's CI: 0.880, 0.917).
specificityas written: “Reader specificity0.918CI 95% Wilson's CI: 0.908, 0.927
source quote (p.11)
Reader specificity improved from 0.890 (95% Wilson's CI: 0.879, 0.900) to 0.918 (95% Wilson's CI: 0.908, 0.927).

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K193417